Dianthus Therapeutics
DNTH
DNTH
44 hedge funds and large institutions have $21.9M invested in Dianthus Therapeutics in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
44
Holding in Top 10
–
Calls
$11K
Puts
–
Top Buyers
| 1 | +$3.79M | |
| 2 | +$2.54M | |
| 3 | +$417K | |
| 4 |
Renaissance Technologies
New York
|
+$66.9K |
| 5 |
CCM
Corsair Capital Management
New York
|
+$50.9K |
Top Sellers
| 1 | -$3.62M | |
| 2 | -$1.38M | |
| 3 | -$1.14M | |
| 4 |
TG
TCW Group
Los Angeles,
California
|
-$596K |
| 5 |
Morgan Stanley
New York
|
-$379K |